Annual EBITDA
-$31.26 M
+$30.83 M+49.66%
31 December 2023
Summary:
NexImmune annual earnings before interest, taxes, depreciation & amortization is currently -$31.26 million, with the most recent change of +$30.83 million (+49.66%) on 31 December 2023. During the last 3 years, it has fallen by -$3.69 million (-13.40%). NEXI annual EBITDA is now -139.74% below its all-time high of -$13.04 million, reached on 31 December 2018.NEXI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$2.65 M
-$11.90 K-0.45%
30 June 2024
Summary:
NexImmune quarterly earnings before interest, taxes, depreciation & amortization is currently -$2.65 million, with the most recent change of -$11.90 thousand (-0.45%) on 30 June 2024. Over the past year, it has increased by +$7.08 million (+72.72%). NEXI quarterly EBITDA is now -0.45% below its all-time high of -$2.64 million, reached on 31 March 2024.NEXI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$19.48 M
+$4.86 M+19.98%
30 June 2024
Summary:
NexImmune TTM earnings before interest, taxes, depreciation & amortization is currently -$19.48 million, with the most recent change of +$4.86 million (+19.98%) on 30 June 2024. Over the past year, it has increased by +$24.32 million (+55.53%). NEXI TTM EBITDA is now -290.33% below its all-time high of -$4.99 million, reached on 31 December 2019.NEXI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NEXI EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +49.7% | +72.7% | +55.5% |
| 3 y3 years | -13.4% | +81.6% | +52.2% |
| 5 y5 years | -139.7% | - | - |
NEXI EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -13.4% | +49.7% | -0.5% | +84.4% | at high | +68.6% |
| 5 y | 5 years | -139.7% | +49.7% | -0.5% | +84.4% | -290.3% | +68.6% |
| alltime | all time | -139.7% | +49.7% | -0.5% | +84.4% | -290.3% | +68.6% |
NexImmune EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$2.65 M(+0.5%) | -$19.48 M(-20.0%) |
| Mar 2024 | - | -$2.64 M(-40.6%) | -$24.34 M(-22.1%) |
| Dec 2023 | -$31.26 M(-49.7%) | -$4.45 M(-54.3%) | -$31.26 M(-28.6%) |
| Sept 2023 | - | -$9.73 M(+29.4%) | -$43.79 M(-10.0%) |
| June 2023 | - | -$7.52 M(-21.4%) | -$48.66 M(-14.4%) |
| Mar 2023 | - | -$9.56 M(-43.7%) | -$56.82 M(-8.5%) |
| Dec 2022 | -$62.09 M(+26.4%) | -$16.98 M(+16.4%) | -$62.09 M(+2.8%) |
| Sept 2022 | - | -$14.60 M(-6.9%) | -$60.39 M(+0.3%) |
| June 2022 | - | -$15.68 M(+5.8%) | -$60.20 M(+6.6%) |
| Mar 2022 | - | -$14.83 M(-3.0%) | -$56.48 M(+15.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$49.13 M(+78.2%) | -$15.28 M(+6.0%) | -$49.13 M(+20.6%) |
| Sept 2021 | - | -$14.41 M(+20.5%) | -$40.74 M(+19.1%) |
| June 2021 | - | -$11.96 M(+60.2%) | -$34.22 M(+18.6%) |
| Mar 2021 | - | -$7.47 M(+8.2%) | -$28.86 M(+4.7%) |
| Dec 2020 | -$27.56 M(+37.1%) | -$6.90 M(-12.6%) | -$27.56 M(+7.5%) |
| Sept 2020 | - | -$7.89 M(+19.6%) | -$25.65 M(+44.4%) |
| June 2020 | - | -$6.60 M(+6.9%) | -$17.76 M(+59.1%) |
| Mar 2020 | - | -$6.17 M(+23.7%) | -$11.16 M(+123.7%) |
| Dec 2019 | -$20.10 M(+54.2%) | -$4.99 M | -$4.99 M |
| Dec 2018 | -$13.04 M | - | - |
FAQ
- What is NexImmune annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for NexImmune?
- What is NexImmune annual EBITDA year-on-year change?
- What is NexImmune quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for NexImmune?
- What is NexImmune quarterly EBITDA year-on-year change?
- What is NexImmune TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for NexImmune?
- What is NexImmune TTM EBITDA year-on-year change?
What is NexImmune annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of NEXI is -$31.26 M
What is the all time high annual EBITDA for NexImmune?
NexImmune all-time high annual earnings before interest, taxes, depreciation & amortization is -$13.04 M
What is NexImmune annual EBITDA year-on-year change?
Over the past year, NEXI annual earnings before interest, taxes, depreciation & amortization has changed by +$30.83 M (+49.66%)
What is NexImmune quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of NEXI is -$2.65 M
What is the all time high quarterly EBITDA for NexImmune?
NexImmune all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$2.64 M
What is NexImmune quarterly EBITDA year-on-year change?
Over the past year, NEXI quarterly earnings before interest, taxes, depreciation & amortization has changed by +$7.08 M (+72.72%)
What is NexImmune TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of NEXI is -$19.48 M
What is the all time high TTM EBITDA for NexImmune?
NexImmune all-time high TTM earnings before interest, taxes, depreciation & amortization is -$4.99 M
What is NexImmune TTM EBITDA year-on-year change?
Over the past year, NEXI TTM earnings before interest, taxes, depreciation & amortization has changed by +$24.32 M (+55.53%)